Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
77 hedge funds and large institutions have $30.2M invested in Mural Oncology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 10 closing their positions.
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 76 → 77 (+1)
0.92% less ownership
Funds ownership: 55.88% → 54.96% (-0.92%)
2% less capital inflows, than outflows
Capital inflows: $6.13M | Capital outflows: $6.23M
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $111K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$311K |
| 2 |
Goldman Sachs
New York
|
+$231K |
| 3 |
Morgan Stanley
New York
|
+$180K |
| 4 |
Virtu Financial
New York
|
+$141K |
| 5 |
Renaissance Technologies
New York
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFA
Alta Fundamental Advisers
New York
|
-$2.25M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.05M |
| 3 |
Centiva Capital
New York
|
-$638K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$469K |
| 5 |
AGM
Alpine Global Management
New York
|
-$457K |
MURA Hedge Fund Activity: Q4 2024 in Review
77 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2024, worth a combined $30.2M — up 1.3% from $29.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MURA positions and 10 closed out — a net gain of 1 holder — while 17 added to existing stakes and 23 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $311K. The largest seller was Alta Fundamental Advisers, exiting entirely with an estimated $2.25M sold.
- 77 institutional investors held Mural Oncology (MURA) as of Q4 2024, up from 76 in Q3 2024.
- Funds reported $30.2M of Mural Oncology stock for Q4 2024, up 1.3% quarter-over-quarter.
- 11 funds opened new Mural Oncology positions in Q4 2024 and 10 closed out, a net change of +1 holder.
- The largest Mural Oncology buyer in Q4 2024 was Citadel Advisors, an estimated $311K added.
- The largest Mural Oncology seller in Q4 2024 was Alta Fundamental Advisers, an estimated $2.25M sold.
Based on aggregated 13F filings for Q4 2024.